Search

9 Jul 2024: said: “We are delighted to have closed the funding round with Cambridge Enterprise and the University of Cambridge Enterprise Fund. ... We are delighted to close this investment on behalf of the University of Cambridge Enterprise Fund.

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: cam.ac.uk/news/wound-care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin Fri, 31 Mar 2023 12:47:26 0000 Life Sciences Spin-outs Ventures animals ... round/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge

9 Jul 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... cells with single chromosome set/a appeared first on a

9 Jul 2024: of Professor Steve Jackson at the Wellcome Trust/Cancer Research UK Gurdon Institute at the University of Cambridge. ... cells with single chromosome set/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: said: “We are delighted to have closed the funding round with Cambridge Enterprise and the University of Cambridge Enterprise Fund. ... We are delighted to close this investment on behalf of the University of Cambridge Enterprise Fund.

9 Jul 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... in the marketplace./p pTechnology licensing, the core of Cambridge Enterprise’s business, had another successful year with 109 licences completed.

9 Jul 2024: of Cambridge gene therapy spin-out is developing a treatment that could prevent the deleterious effects of glaucoma, the leading cause of irreversible blindness worldwide. ... across the research of Professor Martin of the Clinical Neurosciences Group at

9 Jul 2024: cam.ac.uk/news/wound-care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin Fri, 31 Mar 2023 12:47:26 0000 Life Sciences Spin-outs Ventures animals ... round/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge

9 Jul 2024: said: “We are delighted to have closed the funding round with Cambridge Enterprise and the University of Cambridge Enterprise Fund. ... We are delighted to close this investment on behalf of the University of Cambridge Enterprise Fund.

9 Jul 2024: rel="noopener noreferrer"Cycle Pharmaceuticals/a, a Cambridge-based company, the researchers identified six known molecules that they thought might inhibit the PARP enzymes. ... such acknowledged experts at the University of Cambridge and Kings College

9 Jul 2024: met with the Cambridge Vice-Chancellor Professor Sir Leszek Borysiewicz last Friday (2 March), before a day-long seminar involving academics from both institu./p pThe post a ... strong-links-with-brazil/"Event highlights strong links with Brazil/a

9 Jul 2024: internships delivered partly in Cambridge and partly at Unicamp by experts in technology commercialisation, university-business collaboration and entrepreneurship education. ... whole exchange with Cambridge Enterprise professionals has been of great

9 Jul 2024: rel="noopener noreferrer"Cambridge Epigenetix/a,a pioneer in the development of epigenetic sequencing. ... It dates back almost 10 years before the anniversary that Cambridge Enterprise is now celebrating.

9 Jul 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... Together they spent time speaking to potential life science customers based

9 Jul 2024: So that’s why, with the support of Cambridge Enterprise, we founded Healthera. ... University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals.

9 Jul 2024: enterprise.cam.ac.uk"Cambridge Enterprise/a./p preA possible new method for treating pancreatic cancer which enables the body’s immune system to attack and kill cancer cells has been ... cite/div /div /blockquote /div pInitial tests of the combined

9 Jul 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: to Reality, an event Cambridge Enterprise has hosted every year since its founding. ... the animal antibody with human equivalents – for the drug to be successful in humans.

9 Jul 2024: the-zeppelins/"Attack of the Zeppelins/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p preThe battle to bring down the Zeppelins during World ... on Channel 4 on Monday, 26 August, follows University of Cambridge

9 Jul 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: access to Cambridge research and know how in order to accelerate the development of new medicines. ... University laboratories at the Stevenage Bioscience Catalyst, where Cambridge researchers are developing potential new treatments for MS, animal

9 Jul 2024: Fri, 31 Mar 2023 12:47:26 0000 Life Sciences Spin-outs Ventures animals bandage Cambridge & Peterborough Combined Authority cambridge angels cattle Department of Veterinary Medicine Dr Jonathan Powell Innovate UK ... in Brazil/a appeared first on a

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... in December 2006./p pHer tenure as Chief Executive was a period of significant achievement for Cambridge Enterprise.

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

9 Jul 2024: whole exchange with Cambridge Enterprise professionals has been of great value for Inova-Unicamp and for myself. ... here to attend a training programme being delivered by Cambridge Enterprise’s International Outreach Programme (IOP).

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

9 Jul 2024: enterprise.cam.ac.uk"Cambridge Enterprise/a./p preA possible new method for treating pancreatic cancer which enables the body’s immune system to attack and kill cancer cells has been ... suffering with severe peanut allergies,” said Dr Maher Khaled

9 Jul 2024: in the marketplace./p pTechnology licensing, the core of Cambridge Enterprise’s business, had another successful year with 109 licences completed. ... first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... a appeared first on a

9 Jul 2024: Franklin of the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute is developing a new regenerative therapy for multiple sclerosis (MS). ... for drug discovery and development are invited to contact Cambridge Enterprise, the

9 Jul 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... Cambridge, funding a post-doctoral researcher in Martin’s laboratory to work on the design and construction of the

9 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... a appeared first on a

9 Jul 2024: cam.ac.uk/case-studies/xampla-pioneering-a-plastic-free-future/ Tegen Amos Tue, 06 Feb 2024 17:12:02 0000 Amadeus Capital Partners B Corp status cambridge angels CIECH Ventures ... care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin

9 Jul 2024: by University of Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p preThe U.S. ... the animal antibody with human equivalents – for the drug to be successful in humans.

9 Jul 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

9 Jul 2024: a variety of fascinating, often exciting consultancy projects./p /div /blockquote /div pHugh relies on Cambridge Enterprise’s Consultancy Services team to handle all the administrative work surrounding these projects. ... noise of the bells!/p pAs Hugh

9 Jul 2024: the University in December 2006.br / Her tenure as Chief Executive was a period of significant achievement for Cambridge Enterprise. ... in December 2006./p pHer tenure as Chief Executive was a period of significant achievement for Cambridge Enterprise.

9 Jul 2024: Andrew Walsh/cite/div /div /blockquote /div p“XO1 has made great progress with Ichorcumab,” said Dr Andrew Walsh, a technology manager at Cambridge Enterprise. ... Enterprise/a./p preThe University laboratories at the Stevenage Bioscience Catalyst,

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

9 Jul 2024: collaborate-to-identify-new-druggable-targets/"PhoreMost and The Wistar Institute collaborate to identify new druggable targets/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge ... convert this information rapidly into novel

9 Jul 2024: by University of Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p preThe U.S. ... the animal antibody with human equivalents – for the drug to be successful in humans.

9 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... Concept Funding from Cambridge Enterprise Seed Funds in

9 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

9 Jul 2024: for very young companies,” said Dr Anne Dobrée, Head of Seed Funds at Cambridge Enterprise. ... hosting the prestigious European Entrepreneurship Colloquium this year at the University of Cambridge,” the Vice-Chancellor commented.

9 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... other carbon nanomaterials has so far prevented their

9 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... Enecsys secures £25m investment/a appeared first on a

9 Jul 2024: Steve Jackson, who is the University of Cambridge and Cancer Research Uk Professor of Biology and Head of Cancer Research UK (CRUK) Laboratories at the Gurdon institute. ... Steve Jackson, who is the University of Cambridge and Cancer Research UK